Cargando…

Improvement of therapeutic effects of mesenchymal stem cells in myocardial infarction through genetic suppression of microRNA-142

Transplanted mesenchymal stem cells (MSCs) have been shown to contribute to myocardial repair after myocardial infarction (MI), primarily through production and secretion some growth factors and cytokines related to cell survival and regeneration. Further improvement of the therapeutic potential of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Liu-Xue, Wei, Chun-Ling, Guo, Man-Li, Zhang, Yong, Bai, Feng, Ma, Shao-Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5689630/ https://www.ncbi.nlm.nih.gov/pubmed/29156740 http://dx.doi.org/10.18632/oncotarget.20935

Ejemplares similares

MicroRNA-133 overexpression promotes the therapeutic efficacy of mesenchymal stem cells on acute myocardial infarction
por: Chen, Yueqiu, et al.
Publicado: (2017)

Epigenetic Regulation and Functional Characterization of MicroRNA-142 in Mesenchymal Cells
por: Skårn, Magne, et al.
Publicado: (2013)

MicroRNA-132, Delivered by Mesenchymal Stem Cell-Derived Exosomes, Promote Angiogenesis in Myocardial Infarction
por: Ma, Teng, et al.
Publicado: (2018)

Erythrocyte survival is controlled by microRNA-142
por: Rivkin, Natalia, et al.
Publicado: (2017)

Bone marrow mesenchymal stem cells for post-myocardial infarction cardiac repair: microRNAs as novel regulators
por: Wen, Zhuzhi, et al.
Publicado: (2012)

MicroRNAs as Biomarkers for Myocardial Infarction
por: Salic, Kanita, et al.
Publicado: (2012)

MicroRNA-142-3p suppresses cell proliferation, invasion and epithelial-to-mesenchymal transition via RAC1-ERK1/2 signaling in colorectal cancer
por: Xie, Na, et al.
Publicado: (2021)

MicroRNA-133a and Myocardial Infarction
por: Xiao, Yi, et al.
Publicado: (2019)

MicroRNA-210 promotes angiogenesis in acute myocardial infarction
por: Fan, Zhong-Guo, et al.
Publicado: (2018)

MicroRNA-142-3p improves vascular relaxation in uremia
por: Kétszeri, Máté, et al.
Publicado: (2019)

MicroRNA-326-5p enhances therapeutic potential of endothelial progenitor cells for myocardial infarction
por: Li, Xiaoting, et al.
Publicado: (2019)

Novel Applications of Mesenchymal Stem Cell-Derived Exosomes for Myocardial Infarction Therapeutics
por: Ozaki Tan, Sho Joseph, et al.
Publicado: (2020)

Exosomal microRNA‑4516, microRNA‑203 and SFRP1 are potential biomarkers of acute myocardial infarction
por: Liu, Peng, et al.
Publicado: (2023)

Inflammation in myocardial infarction: roles of mesenchymal stem cells and their secretome
por: Shao, Lianbo, et al.
Publicado: (2022)

MicroRNA-142-3p is involved in regulation of MGMT expression in glioblastoma cells
por: Lee, Yi-Yen, et al.
Publicado: (2018)

MicroRNAs—The Heart of Post-Myocardial Infarction Remodeling
por: Maries, Liana, et al.
Publicado: (2021)

Disruption of Cancer Metabolic SREBP1/miR-142-5p Suppresses Epithelial–Mesenchymal Transition and Stemness in Esophageal Carcinoma
por: Huang, Chih-Ming, et al.
Publicado: (2019)

Adropin-based dual treatment enhances the therapeutic potential of mesenchymal stem cells in rat myocardial infarction
por: Li, HuiYa, et al.
Publicado: (2021)

Adipose-Derived Mesenchymal Stem Cells-Derived Exosomes Carry MicroRNA-671 to Alleviate Myocardial Infarction Through Inactivating the TGFBR2/Smad2 Axis
por: Wang, Xue, et al.
Publicado: (2021)

Circulating microRNAs are new and sensitive biomarkers of myocardial infarction
por: D'Alessandra, Yuri, et al.
Publicado: (2010)

MicroRNA Microarray Expression Profiling in Human Myocardial Infarction
por: Boštjančič, Emanuela, et al.
Publicado: (2009)

Circulating microRNAs in patients with ST-elevation myocardial infarction
por: Eryılmaz, Ufuk, et al.
Publicado: (2016)

A gain‐of‐function mutation in microRNA 142 is sufficient to cause the development of T‐cell leukemia in mice
por: Kawano, Shingo, et al.
Publicado: (2023)

MicroRNA-142 is mutated in about 20% of diffuse large B-cell lymphoma
por: Kwanhian, Wiyada, et al.
Publicado: (2012)

MicroRNA-142-5p contributes to Hashimoto’s thyroiditis by targeting CLDN1
por: Zhu, Jin, et al.
Publicado: (2016)

The bimodally expressed microRNA miR‐142 gates exit from pluripotency
por: Sladitschek, Hanna L, et al.
Publicado: (2015)

MicroRNA-142-3p Negatively Regulates Canonical Wnt Signaling Pathway
por: Hu, Tanyu, et al.
Publicado: (2016)

MicroRNA-142 regulates inflammation and T cell differentiation in an animal model of multiple sclerosis
por: Talebi, Farideh, et al.
Publicado: (2017)

microRNA-142 guards against autoimmunity by controlling T(reg) cell homeostasis and function
por: Wang, Wei-Le, et al.
Publicado: (2022)

Tissue and Circulating MicroRNAs 378 and 142 as Biomarkers of Obesity and Its Treatment Response
por: Matveev, Georgy A., et al.
Publicado: (2023)

Comparing the diagnostic values of circulating microRNAs and cardiac troponin T in patients with acute myocardial infarction
por: Li, Ying-Qing, et al.
Publicado: (2013)

The Role of MicroRNAs in Myocardial Infarction: From Molecular Mechanism to Clinical Application
por: Sun, Teng, et al.
Publicado: (2017)

Extracellular matrix remodeling following myocardial infarction influences the therapeutic potential of mesenchymal stem cells
por: Sullivan, Kelly Elizabeth, et al.
Publicado: (2014)

A brief review: the therapeutic potential of bone marrow mesenchymal stem cells in myocardial infarction
por: Miao, Chi, et al.
Publicado: (2017)

Danhong Injection Enhances the Therapeutic Efficacy of Mesenchymal Stem Cells in Myocardial Infarction by Promoting Angiogenesis
por: Chen, Jingrui, et al.
Publicado: (2018)

In vivo imaging to monitor differentiation and therapeutic effects of transplanted mesenchymal stem cells in myocardial infarction
por: Pei, Zhijun, et al.
Publicado: (2017)

Intracellular delivery of nitric oxide enhances the therapeutic efficacy of mesenchymal stem cells for myocardial infarction
por: Hao, Tian, et al.
Publicado: (2023)

MicroRNA Expression Analysis: Clinical Advantage of Propranolol Reveals Key MicroRNAs in Myocardial Infarction
por: Zhu, Wenliang, et al.
Publicado: (2011)

Therapeutic Use of Stem Cells for Myocardial Infarction
por: Madigan, Mariah, et al.
Publicado: (2018)

Prognostic value of circulating microRNA-21-5p and microRNA-126 in patients with acute myocardial infarction and infarct-related artery total occlusion
por: Mi, Xiao-long, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ifp5souhr07dg2aempsgtet4ma